Guangzhou Jet Bio-Filtration Co., Ltd. (SHA:688026)

Market Cap	2.25B +6.6%
Revenue (ttm)	565.36M +1.2%
Net Income	48.21M -33.2%
EPS	0.35 -32.7%
Shares Out	137.63M
PE Ratio	46.80
Forward PE	n/a
Dividend	0.07 (0.45%)
Ex-Dividend Date	Jul 2, 2025

Volume	1,614,848
Average Volume	1,782,207
Open	16.24
Previous Close	16.22
Day's Range	16.07 - 16.47
52-Week Range	13.22 - 21.66
Beta	0.74
RSI	46.56
Earnings Date	Apr 23, 2026

About SHA:688026

Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration products, molecular biology, cellsafe, medical consumables, biological reagents, laboratory equipment, petri dishes, ELISA plates, immuno micro plates, inoculating loops and needles, cuvettes, latex powder-free gloves, NBR gloves, and other products. The company was founded in 2001 and is headquartered in Guangzhou, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 990
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688026

Financial Performance

In 2025, SHA:688026's revenue was 565.36 million, an increase of 1.20% compared to the previous year's 558.66 million. Earnings were 48.21 million, a decrease of -33.21%.